A neutral trehalase gene from Candida albicans: molecular cloning, characterization and disruption.

Microbiology
Raimund EckWaldemer Künkel

Abstract

A neutral trehalase gene, NTC1, from the human pathogenic yeast Candida albicans was isolated and characterized. An ORF of 2724 bp was identified encoding a predicted protein of 907 amino acids and a molecular mass of 104 kDa. A single transcript of approximately 3.2 kb was detected by Northern blot analysis. Comparison of the deduced amino acid sequence of the C. albicans NTC1 gene product with that of the Saccharomyces cerevisiae NTH1 gene product revealed 57% identity. The NTC1 gene was localized on chromosome 1 or R. A null mutant (delta ntc1/delta ntc1) was constructed by sequential gene disruption. Extracts from mutants homozygous for neutral trehalase deletion had only marginal neutral trehalase activity. Extracts from heterozygous mutants showed intermediate activities between extracts from the wild-type strain and from the homozygous mutants. The null mutant showed no significant differences in pathogenicity as compared to the wild-type strain in a mouse model of systemic candidiasis. This result indicates that the neutral trehalase of C. albicans is not a potential target for antifungal drugs.

References

Feb 3, 1975·Biochemical and Biophysical Research Communications·P van Solingen, J B van der Plaat
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Oct 1, 1990·Antonie van Leeuwenhoek·A Wiemken
Jul 1, 1986·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·D R Soll
Apr 1, 1987·The Journal of Antibiotics·N AsanoK Matsui
May 1, 1973·The Biochemical Journal·S G George, J Kenny
Jan 1, 1968·The Biochemical Journal·G G ForstnerK J Isselbacher
Jun 1, 1971·Journal of Bacteriology·E MerdingerB F Booker
Jul 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·B Sacktor
Mar 1, 1984·Microbiological Reviews·J M Thevelein
May 1, 1984·The Journal of Antimicrobial Chemotherapy·M Plempel
Feb 1, 1995·Archives of Biochemistry and Biophysics·S V KyossevaA D Elbein
Feb 1, 1994·Journal of Bacteriology·R C Barton, S Scherer
Jan 1, 1952·Antonie van Leeuwenhoek·T M LUKES, H J PHAFF
Sep 1, 1963·Archives of Biochemistry and Biophysics·E P HILL, A S SUSSMAN

❮ Previous
Next ❯

Citations

Jul 3, 2008·Applied Biochemistry and Biotechnology·Yan LiangJianping Wen
Sep 19, 2003·International Journal for Parasitology·F I PelleroneA C Somerville
Mar 16, 2001·FEMS Microbiology Reviews·F Navarro-GarcíaJ Pla
Jun 19, 2001·Gene·T J OesterreicherS J Henning
Feb 24, 2001·Research in Microbiology·F J Alvarez-Peral, J C Argüelles
Sep 7, 2012·The Journal of Biological Chemistry·Joke SerneelsPatrick Van Dijck
Aug 5, 2009·Infection and Immunity·Popchai NgamskulrungrojJohn R Perfect
Jan 13, 2005·Canadian Journal of Microbiology·Yiu-Kwok Chan, Wayne A McCormick
Mar 5, 2014·Journal of Medicinal Chemistry·Feixia DuanWen Huang
May 17, 2011·Biochimica Et Biophysica Acta·Pilar González-PárragaJuan-Carlos Argüelles
Feb 24, 2009·International Journal of Medical Microbiology : IJMM·María Martínez-EsparzaJuan-Carlos Argüelles
Dec 17, 2008·Protein Expression and Purification·Fabiana M de AlmeidaAline M da Silva
May 22, 2007·Mycological Research·Barbara Wolska-MitaszkoKatarzyna Pszeniczna
Apr 2, 2009·Biochemical and Biophysical Research Communications·Ruth Sánchez-FresnedaJuan-Carlos Argüelles
May 3, 2016·Biochimica Et Biophysica Acta·Sergi MaicasJuan-Carlos Argüelles
Oct 22, 2008·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Janka TeutschbeinSvenja Meierjohann
Jan 12, 2020·Applied Microbiology and Biotechnology·Masayoshi Sakaguchi
Jan 11, 2019·Physiological Research·M AlblovaV Obsilova
Jul 15, 2004·The Journal of Biological Chemistry·Yolanda PedreñoEulogio Valentin
May 11, 1999·Drug Discovery Today·F SpaltmannK Ziegelbauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.